INVENTIVA (EPA:IVA) | WebDisclosure

Basculer en Français

9480	Companies
185543	Keywords
117939	Articles
99384	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 10/07/2025 at 22:00, 1 month 28 days ago

Inventiva présentera plusieurs abstracts lors du congrès AASLD The Liver Meeting® 2025
Inventiva présentera plusieurs abstracts au congrès AASLD The Liver Meeting® 2025. Présentation d'une comparaison histologie numérique sur lame biopsies NATiV3 et pathologie numérique de lanifibranor préclinique

Pathologie Numérique Inventiva Lanifibranor AASLD The Liver Meeting 2025 Histologie Numérique
BRIEF

published on 10/01/2025 at 08:35, 2 months 4 days ago

Andrew Obenshain nommé PDG d'Inventiva

Transition De Leadership Développement De Médicaments Inventiva Traitement MASH André Obenshain
BRIEF

published on 10/01/2025 at 08:35, 2 months 4 days ago

Andrew Obenshain Appointed as CEO of Inventiva

Leadership Transition Drug Development Inventiva MASH Treatment Andrew Obenshain
PRESS RELEASE

published on 10/01/2025 at 08:30, 2 months 4 days ago

Inventiva annonce la nomination d’Andrew Obenshain au poste de Directeur Général
Inventiva annonce la nomination d'Andrew Obenshain au poste de Directeur Général, marquant une transition de leadership stratégique pour la société biopharmaceutique spécialisée dans le traitement de la MASH

Directeur Général Transition De Leadership Inventiva MASH Andrew Obenshain
PRESS RELEASE

published on 10/01/2025 at 08:30, 2 months 4 days ago

Inventiva Appoints Andrew Obenshain as Chief Executive Officer
Inventiva appoints Andrew Obenshain as Chief Executive Officer, succeeding Frédéric Cren, to lead company's growth and prepare for potential commercialization in the United States

Chief Executive Officer Inventiva MASH Frédéric Cren Andrew Obenshain
PRESS RELEASE

published on 09/29/2025 at 13:55, 2 months 6 days ago

RFS
BRIEF

published on 09/24/2025 at 22:05, 2 months 10 days ago

Inventiva organise un événement pour analystes et investisseurs

Phase 3 Événement Inventiva MASH Lanifibranor
BRIEF

published on 09/24/2025 at 22:05, 2 months 10 days ago

Inventiva organizes an event for analysts and investors

Event Phase 3 Inventiva MASH Lanifibranor
PRESS RELEASE

published on 09/24/2025 at 22:00, 2 months 10 days ago

Inventiva to Host Analyst and Investor Event on October 8, 2025
Inventiva to host analyst and investor event on October 8, 2025 featuring updates on lanifibranor and key MASH trends. Renowned experts to share insights on MASH landscape

Inventiva Lanifibranor Analyst Event MASH Trends Expert Insights
PRESS RELEASE

published on 09/24/2025 at 22:00, 2 months 10 days ago

Inventiva organise un événement analystes et investisseurs le 8 octobre 2025
Inventiva organisera un événement pour analystes et investisseurs le 8 octobre 2025 à New York, présentant lanifibranor, traitement de la stéatohépatite (MASH)

Événement Inventiva MASH Analystes Lanifibranor

Accesswire

Published on 12/05/2025 at 20:25, 12 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 22 minutes ago

When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 47 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 17 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 1 hour 52 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 1 hour 39 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 2 hours 10 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 2 hours 21 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 2 hours 45 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 2 hours 50 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 3 hours 19 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 3 hours 19 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 26 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 26 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 6 hours 38 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE